Search results
Showing 4551 to 4600 of 8897 results
Recommendation ID NG27/5 Question Assessment at home to improve hospital discharge success rates:- How effective are home assessment interventions
Recommendation ID NG55/5 Question Assessment models for different groups of children and young people:- How effective are the models currently
Recommendation ID CG153/1 Question Assessment of disease severity and impact:- In children, young people and adults with psoriasis, can
Recommendation ID NG57/4 Question Assessment tools for health promotion:- What are the most effective tools to determine the health promotion
Recommendation ID NG26/5 Question Relationship between attachment difficulties and complex trauma:- This research recommendation is composed
Recommendation ID TA223/1 Question A trial comparing the long-term effectiveness (beyond 24 weeks) of cilostazol, naftidrofuryl oxalate
Recommendation ID NG207/01 Question Prevention of prolonged pregnancy: At what gestational age should induction of labour be offered in
Recommendation ID CG163/5 Question Anti-reflux therapy as a treatment for idiopathic pulmonary fibrosis:- Is anti-reflux therapy an effective
Recommendation ID NG125/3 Question What is the clinical and cost effectiveness of chlorhexidine in alcohol at different concentrations
Recommendation ID NG145/8 Question What is the clinical and cost effectiveness of a block and replace regimen compared with a titration
Recommendation ID NG145/3 Question Are there subgroups of people with Graves' disease who have a particularly good response to antithyroid
Recommendation ID NG145/6 Question What is the clinical and cost effectiveness of different durations of antithyroid drug regimens for
Recommendation ID NG192/03 Question Decision-to-birth interval (category 2 urgency): A prospective study to determine whether the decision-to-birth
Recommendation ID NG119/6 Question Augmentative and alternative communication systems:- Are augmentative and alternative communication
Recommendation ID CG189/10 Question Awareness of risk among black, Asian and other minority ethnic groups: Are black, Asian and other minority
Recommendation ID NG162/2 Question Duration of risk of radiotherapy in people with cancer and COVID-19: Are people who have had radiotherapy
Recommendation ID NG161/2 Question Duration of risk of systemic anticancer treatment in people with cancer and COVID-19: Are people who
Recommendation ID NG119/4 Question Prophylactic antibiotics for respiratory disorders:- Are prophylactic antibiotics clinically and cost
Recommendation ID CG192/5 Question Are psychological interventions effective for treating moderate to severe anxiety disorders (including
Recommendation ID CG120/6 Question Are psychosocial interventions clinically and cost effective when compared with standard care for people
Recommendation ID NG94/14 Question Standardised criteria for hospital discharge:- Are standardised criteria for hospital discharge clinically
Recommendation ID PH44/7 Question Are the Department of Health's 'Let's get moving' physical activity care pathway and the general practice
Recommendation ID NG3/5 Question Are there effective long-term pharmacological interventions to prevent the onset of type 2 diabetes that
Step 1 treatment: Are there subgroups of people with hypertension who should start on dual therapy?
Recommendation ID NG136/04 Question Step 1 treatment: Are there subgroups of people with hypertension who should start on dual therapy
Recommendation ID NG18/02 Question Use of routinely collected real-world data to examine the effectiveness and cost effectiveness of continuous
Recommendation ID NG52/1 Question Baseline FDG-PET-CT imaging for people with diffuse large B-cell lymphoma stage II or above:- In people
Recommendation ID NG134/5 Question What is the clinical and cost effectiveness, post treatment and at longer-term follow‑up, of behavioural
Recommendation ID NG75/3 Question Behavioural interventions:- What is the effectiveness of behavioural interventions compared with usual
Recommendation ID CG164/3 Question Benefits of MRI surveillance in women over 50 years:- Research is recommended to establish the risk
Recommendation ID NG30/3 Question Behaviour change methods and resources:- What behaviour change methods and resources (such as phone apps
Bilateral cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse
Recommendation ID IPG669/1 Question Bilateral cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse
Recommendation ID NG35/5 Question Bisphosphonates for the prevention of bone disease:- What is the effectiveness of monthly zoledronic
Recommendation ID CG148/4 Question Bladder management strategies:- What are the long-term risks and effects on quality of life of different
Recommendation ID CG146/4 Question Bone mineral density (BMD) with FRAX:- What is the added prognostic value of BMD in the assessment of
Recommendation ID NG132/1 Question What is the clinical utility of bone turnover markers in the diagnosis and management of primary...
Recommendation ID CG30/4 Question The effect of injectable contraceptives on bone mineral density in women who have used DMPA for longer
Recommendation ID CG145/3 Question Botulinum toxin type A:- What is the clinical and cost effectiveness of botulinum toxin type A when
Recommendation ID IPG652/1 Question Current evidence on the safety and efficacy of bronchoscopic thermal vapour ablation for upper-lobe
Recommendation ID NG134/4 Question What is the clinical and cost effectiveness, post-treatment and at longer-term follow‑up, of a brief
Recommendation ID NG85/2 Question Cachexia interventions: - A cohort study followed by phase II and III studies should be undertaken in
Recommendation ID NG95/1 Question Core outcome set for studies of management of Lyme disease:- Can a core outcome set be developed for
Recommendation ID NG14/02 Question Safety, prognostic and predictive biomarkers: Can biomarkers be used for risk stratification and treatment
Recommendation ID NG14/01 Question Monitoring and response biomarkers: Can biomarkers accurately classify recurrence, progression and response
Recommendation ID NG119/3 Question Detection and management of respiratory disorders in primary and community care:- Can detection and
Recommendation ID NG68/5 Question Can GP practices deliver effective and cost effective condom schemes to reduce STIs?: -Can condom schemes
Recommendation ID CG191/4 Question Can rapid microbiological diagnosis of hospital-acquired pneumonia reduce the use of xtendedspectrum
Recommendation ID NG196/7 Question Stroke risk assessment: Can routine data from UK primary care databases clarify stroke risk in people
Can vitamin D slow down the progression of disability in Multiple Sclerosis (MS)?
Recommendation ID CG186/5 Question Can vitamin D slow down the progression of disability in Multiple Sclerosis (MS)? Any explanatory
Recommendation ID NG210/11 Question Weight loss for managing pelvic floor dysfunction: Can weight loss reduce symptoms of pelvic floor
Recommendation ID CG173/3 Question What is the clinical and cost effectiveness of carbamazepine as initial treatment for trigeminal neuralgia